[{"id":"20cbe8f6-75d0-403d-869b-ce5c9e0981bf","acronym":"","url":"https://clinicaltrials.gov/study/NCT00000781","created_at":"2021-01-29T06:52:34.871Z","updated_at":"2025-02-25T13:06:59.155Z","phase":"Phase 2","brief_title":"A Randomized, Double-Blind, Four-Arm Study Comparing Combination Nucleoside, Alternating Nucleoside, and Triple-Drug Therapy for the Treatment of Advanced HIV Disease (CD4 \u003c= 50/mm3)","source_id_and_acronym":"NCT00000781","lead_sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","biomarkers":" CD4","pipe":"","alterations":" ","tags":["CD4"],"overall_status":"Completed","enrollment":" Enrollment 1292","initiation":"","start_date":"","primary_txt":"","primary_completion_date":"","study_txt":" Completion: 09/01/1996","study_completion_date":" 09/01/1996","last_update_posted":"2021-11-04"},{"id":"56f6336f-d1a9-4c9d-bad8-061efe7570d9","acronym":"","url":"https://clinicaltrials.gov/study/NCT00000803","created_at":"2021-01-29T06:52:36.837Z","updated_at":"2024-07-02T16:36:21.179Z","phase":"Phase 2","brief_title":"A Phase II Double-Blind Study of Delavirdine Mesylate ( U-90152 ) in Combination With Zidovudine ( AZT ) and/or Didanosine ( ddI ) Versus AZT and ddI Combination Therapy","source_id_and_acronym":"NCT00000803","lead_sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","biomarkers":" CD4","pipe":"","alterations":" ","tags":["CD4"],"overall_status":"Completed","enrollment":" Enrollment 471","initiation":"","start_date":"","primary_txt":"","primary_completion_date":"","study_txt":" Completion: 03/01/1997","study_completion_date":" 03/01/1997","last_update_posted":"2021-11-04"},{"id":"d0e34fc6-8dfa-4b6e-8743-6012fcafba7e","acronym":"REACT-KS","url":"https://clinicaltrials.gov/study/NCT01352117","created_at":"2021-01-29T07:01:54.755Z","updated_at":"2025-02-25T16:23:38.105Z","phase":"Phase 3","brief_title":"Antiretroviral Therapy (ART) Alone or With Delayed Chemo Versus ART With Immediate Chemo for Limited AIDS-related Kaposi's Sarcoma","source_id_and_acronym":"NCT01352117 - REACT-KS","lead_sponsor":"AIDS Clinical Trials Group","biomarkers":" CD4","pipe":"","alterations":" ","tags":["CD4"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e etoposide IV"],"overall_status":"Completed","enrollment":" Enrollment 192","initiation":"Initiation: 11/18/2011","start_date":" 11/18/2011","primary_txt":" Primary completion: 03/16/2016","primary_completion_date":" 03/16/2016","study_txt":" Completion: 11/29/2018","study_completion_date":" 11/29/2018","last_update_posted":"2019-11-14"}]